Unfortunately, WeedMD has no published financial reports, so all the following are guesses. Let's pretend the following happens in a year. I did this really quickly and dirtily (and I'm fairly newb at financials). Correct me if anything is wrong.

Let's take them at their current state. Let's pretend that through private placements, they end up with 100 million shares.

On a production scale wise, I'd say the closest in comparison is Emerald Health. Their expenditures are ~3m per year (based on 2016) for operating costs. Let's pretend that's about what WeedMD uses up as well per annum. That's basically $8m per year at full capacity (using the thread's info), assuming no expansion.

From what it seems like, WeedMD doesn't have much debt, so let's say it's negligible to the calculations. This probably isn't a problem if they raise 36 million in PPs anyway.

Based on this, their EPS is 0.08. Let's pretend their share price is $2 even after all the dilution. That'll give them a 25 P/E. This isn't horrible at all, given that we are talking about weed stocks.